- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 271/04 - 1,2,3-OxadiazolesHydrogenated 1,2,3-oxadiazoles
Patent holdings for IPC class C07D 271/04
Total number of patents in this class: 83
10-year publication summary
|
13
|
8
|
8
|
6
|
3
|
6
|
6
|
2
|
3
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer Cropscience AG | 1841 |
11 |
| Melior Pharmaceuticals II, LLC | 5 |
5 |
| Bayer Pharma AG | 1009 |
4 |
| Caliper Life Sciences, Inc. | 83 |
4 |
| C.n.c.c.s. Scarl Collezione Nazionale DEI Composti Chimici e Centro Screening | 21 |
4 |
| Irbm S.p.A. | 27 |
4 |
| Commissariat à l'énergie atomique et aux energies alternatives | 11124 |
3 |
| Incyte Holdings Corporation | 625 |
3 |
| Bristol-myers Squibb Company | 4751 |
2 |
| BASF SE | 21308 |
2 |
| Syngenta Crop Protection AG | 6710 |
2 |
| Centre National de La Recherche Scientifique | 11026 |
2 |
| Blade Therapeutics, Inc. | 15 |
2 |
| C4X Discovery Limited | 27 |
2 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1024 |
2 |
| Universite de Strasbourg | 712 |
2 |
| Merck Sharp & Dohme LLC | 3736 |
2 |
| F. Hoffmann-La Roche AG | 7819 |
1 |
| Hoffmann-La Roche Inc. | 3796 |
1 |
| The Regents of the University of California | 20778 |
1 |
| Other owners | 24 |